Jump to content

Methylenedioxybenzylamphetamine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Meodipt (talk | contribs) at 06:59, 15 September 2009. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Methylenedioxybenzylamphetamine
Names
IUPAC name
1-(1,3-benzodioxol-5-yl)-N-benzylpropan-2-amine
Identifiers
3D model (JSmol)
  • C1=C3C(=CC=C1CC(C)NCC2=CC=CC=C2)OCO3
Properties
C17H19NO2
Molar mass 269.343 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

MDBZ, or 3,4-methylenedioxy-N-benzylamphetamine, is a lesser-known psychedelic drug. It is also the N-benzyl isomer of MDA. MDBZ was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 150mg, and the duration unknown. MDBZ produces few to no effects. Very few data exist about the pharmacological properties, metabolism, and toxicity of MDBZ.

In an episode of the British spoof documentary TV show Brass Eye, David Amess MP was fooled into recording a warning against a new drug called "cake". When he asked a parliamentary question about it, the Home Office assumed he meant 3,4-methylenedioxy-N-benzylamphetamine [1].

References

  1. ^ "House of Commons Hansard Written Answers for 23 Jul 1996 (pt 10)".

See also

Template:PiHKAL